Recent Finacing
Recent Raise
Actym Therapeutics develops the STACT platform using attenuated S. Typhimurium to selectively localize in solid tumors and deliver multiplexed immunomodulatory payloads (e.g., IL‑15, STING) to reactivate the tumor microenvironment.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
